{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:21:51Z","timestamp":1790904111276,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2139,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2230.2009.03698.x","type":"journal-article","created":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T14:38:53Z","timestamp":1256308733000},"page":"658-663","source":"Crossref","is-referenced-by-count":97,"title":["In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis"],"prefix":"10.1093","volume":"35","author":[{"given":"J. G.","family":"Bueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sanclemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,10,23]]},"reference":[{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-4362.2000.00812.x","article-title":"Onychomycosis: clinical perspective","volume":"39","author":"Sehgal","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB2|cit2","first-page":"240","article-title":"Enfermedades de la piel m\u00e1s frecuentes en la consulta dermatol\u00f3gica del hospital universitario San Vicente de Pa\u00fal y del Hospital Infantil, Medell\u00edn, Colombia 1999","volume":"26","author":"Sanclemente","year":"2001","journal-title":"Acta Med Colomb"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB3|cit3","volume-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Freedberg","year":"2003"},{"issue":"Suppl. 60","key":"10.1111\/j.1365-2230.2009.03698.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.2001.145s60003.x","article-title":"The future of onychomycosis therapy may involve a combination of approaches","volume":"145","author":"Hay","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1469-0691.2003.00592.x","article-title":"Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFSTEUCAST)","volume":"9","author":"Cuenca-Estrella","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB6|cit6","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard","author":"Committee for Clinical Laboratory Standards","year":"2002"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2133.1976.tb05171.x","article-title":"Nails and fungi","volume":"94","author":"English","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB8|cit8","first-page":"301","volume-title":"Atlas of Clinical Fungi","author":"De Hoog","year":"1995"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/B978-0-12-372180-8.50038-X","volume-title":"PCR Protocols. A Guide to Methods and Applications","author":"Lee","year":"1990"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1073\/pnas.95.5.2044","article-title":"Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies","volume":"95","author":"O\u2019Donnell","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1128\/JCM.42.10.4444-4448.2004","article-title":"Origins of microsatellite diversity in the Trichophyton rubrum-T. violaceum clade (dermatophytes)","volume":"42","author":"Ohst","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/AAC.01177-06","article-title":"Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates","volume":"51","author":"Alastruey-Izquierdo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1128\/JCM.43.4.1917-1920.2005","article-title":"Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum","volume":"43","author":"Santos","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2133.2003.05418.x","article-title":"In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity","volume":"149","author":"Gupta","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","volume":"43","author":"Ghannoum","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1130-1406(08)70027-5","article-title":"Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi","volume":"25","author":"Espinel-Ingroff","year":"2008","journal-title":"Rev Iberoam Micol"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1439-0507.2006.01351.x","article-title":"Onychomycosis","volume":"50","author":"Seebacher","year":"2007","journal-title":"Mycoses"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/B:MYCO.0000041866.85314.e4","article-title":"Onychomycosis in Cali, Colombia","volume":"158","author":"Alvarez","year":"2004","journal-title":"Mycopathologia"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB19|cit19","first-page":"251","article-title":"Comportamiento de los agentes etiologicos de las onicomicosis en un laboratorio de micologia de referencia (Medell\u00edn 1994-2003)","volume":"33","author":"Zuluaga","year":"2005","journal-title":"Med Cutan Ibero Lat Am"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00128071-200304010-00005","article-title":"Terbinafine: a review of its use in onychomycosis in adults","volume":"4","author":"Darkes","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB21|cit21","first-page":"319","article-title":"Onychomycoses caused by nondermatophytic filamentous fungi in Cadiz","volume":"18","author":"Garcia-Martos","year":"2000","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1365-4632.2007.03120.x","article-title":"Fusarium spp. as agents of onychomycosis in immunocompetent hosts","volume":"46","author":"Guilhermetti","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2003.09.003","article-title":"In vitro interactions of licensed and novel antifungal drugs against Fusarium spp","volume":"48","author":"Ortoneda","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0733-8635(03)00036-6","article-title":"Treatment of nondermatophyte mold and Candida onychomycosis","volume":"21","author":"Tosti","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jac\/dkh228","article-title":"In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi","volume":"53","author":"Garcia-Effron","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1365-2230.2009.03698.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijantimicag.2007.04.004","article-title":"In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis","volume":"30","author":"Carrillo-Mu\u00f1oz","year":"2007","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2009.03698.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2009.03698.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:07:25Z","timestamp":1676383645000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/35\/6\/658\/6622294"}},"subtitle":["Activity of fluconazole, itraconazole, voriconazole and terbinafine against onychomycosis"],"short-title":[],"issued":{"date-parts":[[2009,10,23]]},"references-count":26,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03698.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,23]]}}}